Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/2547
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSugarman, Jeremy-
dc.date.accessioned2024-12-12T07:28:31Z-
dc.date.available2024-12-12T07:28:31Z-
dc.date.issued2024-
dc.identifier.urihttps://hdl.handle.net/20.500.14356/2547-
dc.descriptionPresentationen_US
dc.description.abstractOverview A definition and related terminology The emerging DCT ecosystem Ethics for DCTs: Belmont and beyond Ethics and DCTs Concluding commentsen_US
dc.language.isoen_USen_US
dc.publisher24th FERCAP International Conferenceen_US
dc.subjectEthical Opportunitiesen_US
dc.subjectEthical Opportunitiesen_US
dc.subjectEthical Challengesen_US
dc.subjectClinical Trialsen_US
dc.subjectUnique Considerations for Researchen_US
dc.subjectLow-and Middle-Income Countriesen_US
dc.subjectUnique Considerations for Research in Low-and Middle-Income Countriesen_US
dc.titleEthical Opportunities and Challenges of Decentralized Clinical Trials: Unique Considerations for Research in Low-and Middle-Income Countriesen_US
dc.typeOtheren_US
Appears in Collections:DAY I: Plenary Session: Adressing Ethical Challenges in Health Research and Innovation; Session Chairs: Juntra Laothavorn (SIDCER-FERCAP President; Ramesh Kant Adhikari, ERB Chair, NHRCNovember 25, 2024



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.